These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 5420766

  • 1. Changes in the electrophoretic mobility and growth pattern of Ehrlich carcinoma cells following transplantation in tumour-bearing mice.
    Halleraker B, Hartveit F.
    J Pathol; 1970 Feb; 100(2):P8. PubMed ID: 5420766
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of subcutaneous transplants of Ehrlich carcinoma on the survival time of mice with intraperitoneal transplants of the same tumour.
    Hartveit F, Halleraker B.
    J Pathol; 1971 Oct; 105(2):85-93. PubMed ID: 5135341
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interaction of transplants of the Ehrlich carcinoma. Lack of local reaction to subcutaneous transplants in the presence of late intraperitoneal tumour.
    Hartveit F, Cater DB.
    Acta Pathol Microbiol Scand A; 1971 Oct; 79(5):423-31. PubMed ID: 4107703
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of growth of Erlich tumors in Swiss mice by diphtheria toxin.
    Buzzi S, Maistrello I.
    Cancer Res; 1973 Oct; 33(10):2349-53. PubMed ID: 4741933
    [No Abstract] [Full Text] [Related]

  • 7. Electrophoretic mobility of Ehrlich ascites carcinoma cells grown in vitro or in vivo.
    Mayhew E.
    Cancer Res; 1968 Aug; 28(8):1590-5. PubMed ID: 5673572
    [No Abstract] [Full Text] [Related]

  • 8. Transplantation of tumor by blood from tumor-bearing mice.
    Mori N.
    Kumamoto Med J; 1969 Sep 30; 22(3):124-32. PubMed ID: 5370527
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hematologic changes in rats inoculated intraperitoneally with Ehrlich ascites carcinoma.
    Dabrowska B, Janik P, Radwański Z, Dux K.
    Arch Immunol Ther Exp (Warsz); 1966 Sep 30; 14(6):724-9. PubMed ID: 5957994
    [No Abstract] [Full Text] [Related]

  • 12. Changes in the electrophoretic mobility of mouse lymphocytes, thymocytes, macrophages and tumour cells following immunisation.
    Hartveit F, Cater DB, Mehrishi JN.
    Br J Exp Pathol; 1968 Dec 30; 49(6):634-47. PubMed ID: 5706992
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The effect of Ehrlich carcinoma RNA on the transplantability and growth of that tumor].
    Vinter VG.
    Vopr Onkol; 1967 Dec 30; 13(3):58-62. PubMed ID: 5613582
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Further evidence on migration of lymphoid cells to peritoneal injection site of an antitumor phosphomucolipid in ascites tumor-bearing mice.
    Mita A, Nakazawa M, Yamamoto T.
    Jpn J Exp Med; 1974 Aug 30; 44(4):311-9. PubMed ID: 4610234
    [No Abstract] [Full Text] [Related]

  • 17. The "non-specific" inflammatory response to subcutaneous transplants of the Ehrlich carcinoma.
    Hartveit F, Halleraker B.
    J Pathol; 1970 Feb 30; 100(2):P8. PubMed ID: 5420765
    [No Abstract] [Full Text] [Related]

  • 18. The effect of xenogenic and allogeneic tumor cells on experimental metastasis with Ehrlich carcinoma.
    Hasegawa Y, Irikura T, Mizuno DI.
    Chem Pharm Bull (Tokyo); 1970 Nov 30; 18(11):2322-6. PubMed ID: 5494853
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.